No Data
No Data
Healthcare Outlook 2025: Healthcare and Biotech to Regain Investor Focus | ASX:AVR, OTC:AMEUF
Anteris Technologies' IPO Underwriters' Representatives Partially Exercise Over-Allotment Option; Shares Up 3%
Anteris Technologies Global Corp. (AVR) Receives a New Rating From TD Cowen
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Anteris Technologies Global Corp. (AVR)
Anteris Technologies Global Corp: Daily Stabilisation Activity Report - 27 December 2024
Anteris Technologies Announces New Director Appointment